This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Chia-Tse Shu: Innovator in Immunogenic Protein Carriers
Introduction: Chia-Tse Shu, an accomplished inventor based in Tainan County, Taiwan, has made significant advances in the field of immunology. His research primarily focuses on the development of novel immunogenic protein carriers that play a critical role in enhancing immune responses. With one patent to his name, he is a key figure in bridging the gap between fundamental science and practical applications in medicine.
Latest Patents: Chia-Tse Shu holds a patent for an "Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain." This innovative protein carrier features both an antigen presenting cell binding domain and a cysteine-rich domain. The patent also describes an immunoconjugate that incorporates the protein carrier with an antigen conjugated to multiple cysteine residues in the cysteine-rich domain. Additionally, it outlines an immune composition that includes the immunoconjugate and an adjuvant, along with their various uses in eliciting immune responses.
Career Highlights: Currently, Chia-Tse Shu is affiliated with Academia Sinica, where he continues to conduct groundbreaking research. His work is pivotal in understanding and developing strategies for enhancing immune system functions through innovative protein carriers.
Collaborations: Throughout his career, Chia-Tse Shu has collaborated with notable colleagues such as Jaulang Hwang and Chun-Cheng Lin. These partnerships have further enriched his research endeavors and contributed to advancements in the field of immunology.
Conclusion: Chia-Tse Shu is a remarkable inventor whose contributions to immunology through the development of immunogenic protein carriers mark a significant step forward in the medical field. His work not only reflects his dedication to scientific innovation but also highlights the importance of collaboration in research, paving the way for future advancements in immune therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
